Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -6.67%275.14M | -12.16%276.07M | -12.16%276.07M | 6.28%313.92M | 15.75%289.18M | 30.81%294.81M | 35.37%314.3M | 35.37%314.3M | 48.27%295.39M | 38.90%249.83M |
-Cash and cash equivalents | -6.67%275.14M | -12.16%276.07M | -12.16%276.07M | 6.28%313.92M | 15.75%289.18M | 30.81%294.81M | 35.37%314.3M | 35.37%314.3M | 48.27%295.39M | 38.90%249.83M |
Receivables | 11.03%206.69M | 20.05%233.74M | 20.05%233.74M | 4.83%202.73M | 15.46%191.69M | 27.70%186.15M | -5.53%194.7M | -5.53%194.7M | -15.81%193.39M | -31.83%166.02M |
-Accounts receivable | 11.03%206.69M | 20.05%233.74M | 20.05%233.74M | 4.83%202.73M | 15.46%191.69M | 27.70%186.15M | -5.53%194.7M | -5.53%194.7M | -15.81%193.39M | -31.83%166.02M |
Inventory | -28.59%180.9M | -8.17%199.23M | -8.17%199.23M | 7.82%214.57M | -3.88%240.81M | -17.66%253.32M | -24.66%216.95M | -24.66%216.95M | -34.87%199M | -5.65%250.52M |
Prepaid assets | 6.86%53.02M | --54.65M | --54.65M | 3.35%51.1M | 3.14%51.04M | 0.24%49.61M | ---- | ---- | 1.95%49.45M | 1.95%49.48M |
Restricted cash | ---- | 10.05%54.65M | 10.05%54.65M | ---- | ---- | ---- | 0.34%49.66M | 0.34%49.66M | ---- | ---- |
Other current assets | 78.90%32.1M | 76.84%31.19M | 76.84%31.19M | 126.36%38.25M | 97.66%31.46M | 27.13%17.94M | 44.75%17.64M | 44.75%17.64M | 21.56%16.9M | -57.25%15.92M |
Total current assets | -6.73%747.85M | 0.21%794.87M | 0.21%794.87M | 8.81%820.57M | 9.89%804.17M | 8.00%801.84M | 0.68%793.25M | 0.68%793.25M | -5.37%754.12M | -5.54%731.77M |
Non current assets | ||||||||||
Net PPE | 11.00%193.6M | 11.85%203.07M | 11.85%203.07M | 12.26%181.98M | 14.39%179.55M | 18.56%174.42M | 23.02%181.55M | 23.02%181.55M | 21.43%162.11M | 19.48%156.96M |
-Gross PPE | ---- | 15.01%338.35M | 15.01%338.35M | 12.26%181.98M | ---- | --174.42M | 19.72%294.21M | 19.72%294.21M | --162.11M | --156.96M |
-Accumulated depreciation | ---- | -20.08%-135.28M | -20.08%-135.28M | ---- | ---- | ---- | -14.76%-112.65M | -14.76%-112.65M | ---- | ---- |
Investments and advances | 33.23%20.64M | 1.23%17.33M | 1.23%17.33M | -0.85%16.88M | -12.48%17.3M | 10.10%15.49M | 84.70%17.12M | 84.70%17.12M | 104.28%17.02M | 134.23%19.77M |
Non current deferred assets | ---- | 4.99%8.88M | 4.99%8.88M | ---- | ---- | ---- | -4.82%8.46M | -4.82%8.46M | ---- | ---- |
Other non current assets | -9.90%29.31M | -5.35%7.19M | -5.35%7.19M | -12.97%29.3M | -23.52%29.12M | 32.27%32.53M | -0.01%7.59M | -0.01%7.59M | 47.83%33.67M | 69.18%38.08M |
Total non current assets | 9.49%243.55M | 10.13%236.46M | 10.13%236.46M | 7.22%228.17M | 5.20%225.97M | 19.74%222.44M | 23.88%214.72M | 23.88%214.72M | 29.28%212.8M | 32.34%214.81M |
Total assets | -3.21%991.4M | 2.32%1.03B | 2.32%1.03B | 8.46%1.05B | 8.83%1.03B | 10.35%1.02B | 4.86%1.01B | 4.86%1.01B | 0.57%966.92M | 1.02%946.58M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -49.90%37.83M | -28.43%92.98M | -28.43%92.98M | -14.88%45.33M | 15.33%50.51M | -4.49%75.51M | 47.33%129.92M | 47.33%129.92M | -54.46%53.25M | -67.24%43.8M |
-accounts payable | -64.44%23.05M | -68.03%17.77M | -68.03%17.77M | 14.51%30.89M | 190.61%36.41M | 83.22%64.81M | 54.31%55.59M | 54.31%55.59M | -61.86%26.98M | -85.64%12.53M |
-Total tax payable | 38.12%14.78M | 73.74%13.11M | 73.74%13.11M | -45.04%14.44M | -54.90%14.1M | -75.50%10.7M | -82.09%7.54M | -82.09%7.54M | -43.13%26.28M | -32.65%31.27M |
-Dividends payable | ---- | 1.04%51.37M | 1.04%51.37M | ---- | ---- | ---- | 7,257.16%50.84M | 7,257.16%50.84M | ---- | ---- |
-Other payable | ---- | -32.72%10.73M | -32.72%10.73M | ---- | ---- | ---- | 70.53%15.95M | 70.53%15.95M | ---- | ---- |
Current accrued expenses | -3.80%130.28M | 17.28%70.29M | 17.28%70.29M | 69.21%131.14M | 71.32%134.95M | 143.38%135.43M | -13.28%59.93M | -13.28%59.93M | -26.78%77.5M | -31.14%78.77M |
Current provisions | ---- | 79.27%5.97M | 79.27%5.97M | ---- | ---- | ---- | -48.56%3.33M | -48.56%3.33M | ---- | ---- |
Current debt and capital lease obligation | ---- | 7.90%2.53M | 7.90%2.53M | ---- | ---- | ---- | -26.87%2.34M | -26.87%2.34M | ---- | ---- |
-Current capital lease obligation | ---- | 7.90%2.53M | 7.90%2.53M | ---- | ---- | ---- | -26.87%2.34M | -26.87%2.34M | ---- | ---- |
Current deferred liabilities | ---- | 15.02%7.41M | 15.02%7.41M | ---- | ---- | ---- | -6.82%6.44M | -6.82%6.44M | ---- | ---- |
Other current liabilities | ---- | 87.50%20.33M | 87.50%20.33M | ---- | ---- | ---- | 8.57%10.85M | 8.57%10.85M | ---- | ---- |
Current liabilities | -20.30%168.11M | -6.25%199.5M | -6.25%199.5M | 34.97%176.48M | 51.31%185.46M | 56.60%210.94M | 15.74%212.81M | 15.74%212.81M | -41.31%130.76M | -50.60%122.57M |
Non current liabilities | ||||||||||
Other non current liabilities | -14.89%50.97M | -1.50%59.55M | -1.50%59.55M | 0.90%62.67M | -6.78%60.18M | 32.42%59.88M | 35.00%60.46M | 35.00%60.46M | 40.12%62.11M | 46.71%64.56M |
Total non current liabilities | -14.89%50.97M | -1.50%59.55M | -1.50%59.55M | 0.90%62.67M | -6.78%60.18M | 32.42%59.88M | 35.00%60.46M | 35.00%60.46M | 40.12%62.11M | 46.71%64.56M |
Total liabilities | -19.11%219.08M | -5.20%259.05M | -5.20%259.05M | 24.00%239.15M | 31.27%245.64M | 50.52%270.82M | 19.51%273.27M | 19.51%273.27M | -27.80%192.87M | -35.94%187.13M |
Shareholders'equity | ||||||||||
Share capital | ---- | 0.82%1.35M | 0.82%1.35M | ---- | ---- | ---- | 1.13%1.34M | 1.13%1.34M | ---- | ---- |
-common stock | ---- | 0.82%1.35M | 0.82%1.35M | ---- | ---- | ---- | 1.13%1.34M | 1.13%1.34M | ---- | ---- |
Retained earnings | ---- | 5.22%432.62M | 5.22%432.62M | ---- | ---- | ---- | -3.28%411.16M | -3.28%411.16M | ---- | ---- |
Paid-in capital | ---- | 5.27%337.98M | 5.27%337.98M | ---- | ---- | ---- | 5.76%321.05M | 5.76%321.05M | ---- | ---- |
Gains losses not affecting retained earnings | ---- | -70.69%338K | -70.69%338K | ---- | ---- | ---- | -55.57%1.15M | -55.57%1.15M | ---- | ---- |
Total stockholders'equity | 2.50%772.33M | 5.12%772.28M | 5.12%772.28M | 4.59%809.59M | 3.30%784.5M | 0.69%753.46M | 0.29%734.7M | 0.29%734.7M | 11.48%774.05M | 17.76%759.44M |
Total equity | 2.50%772.33M | 5.12%772.28M | 5.12%772.28M | 4.59%809.59M | 3.30%784.5M | 0.69%753.46M | 0.29%734.7M | 0.29%734.7M | 11.48%774.05M | 17.76%759.44M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |